Hemo Organic Ltd.
Snapshot View

View in App

Prices View details >>

7.39 ▼0%

21 March 2023, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.hemoorganicltd.com
Market Cap 2.57 Cr.
Enterprise Value(EV) 2.60 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.18 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 31.70 Trailing Twelve Months Ending 2022-03
Book Value / Share 0.00 Trailing Twelve Months Ending 2022-03
Price to Book Value 5,700.00 Calculated using Price: 7.41
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.35 Cr. 3,465,900 Shares
FaceValue 10
Company Profile
Dinesh Allorga incorporated as public limited Company in August 1992. It is engaged in production and sale of ayurvedic medicines and chemicals.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-3.65%
1 Month
-19.67%
3 Month
-35.46%
6 Month
-69.46%
1 Year
-79.97%
2 Year
-51.70%
5 Year
-48.14%
10 Year
-49.00%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.48 -7.77 -99.33 -19.17 -44.90 -61.38 -17.52 -53.35 -180.16
Return on Capital Employed (%) 3.35 -7.51 -96.61 -19.17 -39.88 -43.09 -11.35 -44.09 -89.20
Return on Assets (%) 2.31 -7.67 -101.27 -11.32 -15.99 -14.38 -4.75 -47.99 -65.16

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1 1 0 0 0 0 0 0
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 0 0 0 1 1 1 0 0 0 0
Minority Int.
Equity & Liab. 2 1 0 1 1 1 0 0 0 0
Non Curr. Assets 1 1 0 0
Curr. Assets 0 0 0 1 1 1 0 0 0 0
Misc. Exp. not W/O
Total Assets 2 1 0 1 1 1 0 0 0 0

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1 0 0 1 0 0 0 0 0
Other Income 0
Total Income 1 0 0 1 0 0 0 0 0
Total Expenditure -1 0 0 -1 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0 0 0
Interest 0
Depreciation 0 0 0
Taxation
Exceptional Items 0 -1
PAT 0 0 -1 0 0 0 0 0 0 0
Adjusted EPS 0 0 -2 0 0 0 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -1 0 0 0 0 0
Cash Fr. Inv. 0 0 1 0 0 0
Cash Fr. Finan. 0 0 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 16.85 16.85 16.85 16.85 16.85 16.85 16.85 16.85 16.85
Public 83.15 83.15 83.15 83.15 83.15 83.15 83.15 83.15 83.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 06 Feb 2023
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On February 06 2023
Board of Directors of the Company in their Board Meeting held on today i.e. on February 06 2023 at the Registered Office of the Company which was commenced at 04:00 P.M. and concluded at 04:30 P.M. have apart from other
businesses considered approved and taken on record the Unaudited Standalone Financial Results
of the Company for the quarter ended on December 31 2022 along with Limited Review Reports
Mon, 06 Feb 2023
Results_Financial Results For 12/31/2022
Submission of Unaudited Standalone Financial Results of the Company for the quarter ended on December 31 2022 along with Limited Review Report.
Mon, 30 Jan 2023
Board Meeting Intimation for Board Meeting Scheduled To Be Held On Monday February 06 2023
Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of our Company is scheduled to be held on Monday February 06 2023 at the registered office of the Company situated at 8-A Gulnar Chinar - Gulnar Appt. V V Nagar Road Anand -388001 to consider approve and take on record the Un-audited Financial Result of the Company for the quarter ended on December 31 2022 as per Regulation 33 of the Listing Regulation and any other items as may be decided by the Board of Directors.In this connection and in continuation of our intimation regarding Closure of Trading Window for the Insiders of the Company vide letter dated December 30 2022 the trading window for dealing in the securities of the Company is already closed for the Insiders of the Company from January 01 2023 till 48 hours after the declaration of Financial Results for the quarter ended December 31 2022.

Technical Scans View Details >>

Tue, 21 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,409.20 -0.2%
Divi's Laboratories Ltd. 73,553.38 2,770.90 +0.1%
Cipla Ltd. 69,632.88 863.00 +0.1%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,270.00 -0.1%
Torrent Pharmaceuticals Ltd. 51,277.87 1,514.10 -0.1%
Zydus Lifesciences Ltd. 48,378.30 479.10 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,409.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-12 26.39 863.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,270.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,514.10 -0.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 479.10 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,409.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-12 3.07 863.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,270.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,514.10 -0.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 479.10 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,409.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-03 0.04 863.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,270.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,514.10 -0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.10 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,409.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-03 13.10 863.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,270.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.10 -0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.10 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,409.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-03 13.10 863.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,270.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.10 -0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.10 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,409.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 863.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,270.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,514.10 -0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.10 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,409.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 863.00 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,270.00 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,514.10 -0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.10 +0.2%

FAQ's On Hemo Organic Ltd.

What is Hemo Organic share price?
Can I buy Hemo Organic shares now?
What is the Market Cap of Hemo Organic?
What are the key metrics to analyse Hemo Organic?
What is the 52 Week High and Low of Hemo Organic?